Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Qiagen Inc
    Registered Vendor
    • Dec 2015
    • 3

    #1

    Scientist/ Senior Scientist, Nucleic Acid Amplification (NGS)

    Scientist/ Senior Scientist, Nucleic Acid Amplification, NGS Technologies will be responsible for development of novel, streamlined methods of nucleic acid processing and amplification compatible with Qiagen’s NGS workflows. In this role, Scientist/ Senior Scientist will focus on near and long term improvements to existing Gene Reader workflows as well as perform research on novel internal and external technologies which will expand the range of applications and capabilities supported by future NGS workflows/platforms. The position will have a key role in bringing innovative solutions to current and future NGS platforms and expanding the range of applications served by these platforms. Scientist/ Senior Scientist will be working closely with Sample Prep and Sequencing, NGS Technologies as well as Engineering, NGS Technologies to ensure seamless integration of novel technologies into QIAGEN’s NGS portfolio.


    In this role Scientist/ Senior Scientist, Nucleic Acid Amplification, will:


    Investigate and develop technologies and approaches (internal and external) to DNA and RNA libraries clonal amplification processes which significantly improve performance and capabilities of the Gene Reader workflow

    Work closely with Sequencing Chemistry developers to migrate these improvements into the Gene Reader workflows

    Evaluate external technologies and engage in external collaborations to bring novel technologies to QIAGEN’s NGS portfolio

    Play a key role in the development of future improvements, technological advances in the QIAGEN NGS platform and expansion of intellectual property
    Participate in collaborations with key external partners (industry and academia)

    Mentor and develop staff

    Deliver key insights into product application opportunities for the QIAGEN NGS platform

    REQUIREMENTS


    PhD/MS in Biology, Chemistry, Biochemistry, Bioengineering or related fields
    At least 5-10 years of relevant industry experience (NGS and adjacent technologies)

    Experience with solid phase nucleic acid amplification and detection technologies

    Experience with variety nucleic acid amplification and modification enzymes and schemes (i.e., PCR, RCA, LCR etc.)

    Experience with diagnostic assay development and regulatory environment is a plus

    Excellent understanding of the underlying technical principles of next generation sequencing chemistries and workflows, associated instrumentation platforms and data analysis and interpretation algorithms

    Mandatory experience in next generation sequencing (NGS) technology development (DNA amplification, sample preparation, chemistry, instrumentation)

    Very good troubleshooting and problem solving skills

    Proven leadership and successful decision-making qualities

    Strong technical writing and presentation skills

    Moderate travel required (up to 10%)


    To apply, please follow the link below:



    Qiagen is an Equal Opportunity Employer and do not discriminate against any employee or applicant for employment because of race, color, sex, age, national origin, religion, sexual orientation, gender identity, status as a veteran, and basis of disability or any other federal, state or local protected class.

Latest Articles

Collapse

  • SEQadmin2
    Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
    by SEQadmin2



    CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

    Despite this, “CRISPR helped turn genome editing from a specialized technique into
    ...
    07-31-2026, 11:01 AM
  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 07:41 AM
0 responses
12 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-03-2026, 10:13 AM
0 responses
30 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-31-2026, 02:55 AM
0 responses
39 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-24-2026, 12:17 PM
0 responses
26 views
0 reactions
Last Post SEQadmin2  
Working...